Home › Kanser sa Tiyan › Texas › Dallas

Pag-aaral pangklinika para sa Kanser sa Tiyan sa Dallas, TX

19 pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Dallas (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

UT Southwestern, Dallas

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Nagre-recruitPhase 3

Baylor Scott & White Health, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07700979

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Baylor, Scott and White Research Institute, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Nagre-recruitPhase 1

Texas Oncology - DFW (Sammons CC), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Nagre-recruitPhase 1

Texas Oncology - DFW (Sammons CC), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Nagre-recruitPhase 3

Research Site, Dallas
Research Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06750185

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Nagre-recruitPhase 1

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06253871

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Nagre-recruitPhase 3

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Texas Oncology, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT03526835

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
UT Southwestern Medical Center - Redbird, Dallas
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Nagre-recruitPhase 2

Texas Oncology - DFW, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06695845

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Nagre-recruitPhase 2

Texas Oncology Dallas Methodist, Dallas
Texas Oncology Dallas Medical City, Dallas
Texas Oncology Dallas Presbyterian, Dallas
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06038578

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Nagre-recruitPhase 1/2

University of Texas Southwestern Medical Center, Dallas

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07432633

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT05768932

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07317505

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas
University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

Pag-aaral para sa Kanser sa Tiyan sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.